WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'8601 Infant (under 12 months) mortality rate: 692
GDP / capita (US$): 5'2461 Child (under 5 years) mortality rate: 1042

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 1'231  1'212  1'193  1'174  1'154  1'064  863  603 
Births 37  37  37  36  36  34  37  29 
Surviving infants 35  34  34  34  33  31  34  26 
Pop. less than 5 years 169  167  164  162  160  157  166  119 
Pop. less than 15 years 469  467  463  462  461  474  415  294 
Female 15-49 years 318  313  307  300  293  259  207  138 

Number of reported case

(Click for retrospective incidence data for Swaziland)
Diphtheria
Japanese encephalitis
Measles 313  26  10  1'465 
Mumps 6'773  7'602  1'058 
Pertussis 20 
Polio* 192 
Rubella 23  20  93  138  26  115 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Swaziland)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   87.8  68  98  98  57  70  90  96 
DTP1 2009  98  MICS   87.8  97  98  95  79  87  99* 
DTP3 2009  91  MICS   87.8  95  91  89  72  80  98  89 
HepB_BD         
HepB3 2009  91  MICS   87.8  95  91  89  72  80 
Hib3 2009  91  MICS   87.8  95  91  89  72 
JapEnc         
MCV 2009  98  MICS   87.8  88  98  94  72  69  80  85 
MCV2          52  74  96  70 
PCV1         
PCV3         
Pol3 2009  85  MICS   87.8  92  85  89  68  80  97  89 
Rota1         
Rota_last         
Rubella1         
TT2plus          53  79  90  99*  94  76 
PAB         
VAD1          41  23  100  63  29 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Swaziland)
BCG 98  98  98  97  96  88  96 
DTP1 97  98  95  95  96  94  96 
DTP3 95  91  89  88  88  84  89 
HepB3 95  91  89  88  90  83 
Hib3 95  91  89  89 
MCV 88  98  94  94  94  92  85 
PAB 86  86  86  86  86  80  63 
PCV3
Pol3 92  85  89  89  89  87  89 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 25
From 80 to 89% 0
From 50 to 79% 75
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 18 months; 5 years; Yes
Pneumo_conj Yes From October 2013
TT 1st contact pregnancy; +1, +6 months; +1,+1 years; CBAW
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 25  100  50 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 25     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100    100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.